Tangible Shareholders Equity: The value shareholders equity less intangible assets.
MIRA Pharmaceuticals, Inc. (MIRA) had Tangible Shareholders Equity of $6.84M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
-- |
|
$-1.42M |
|
-- |
|
-- |
|
$1.41M |
|
$-1.41M |
|
$-0.01M |
|
$-1.42M |
|
$-1.42M |
|
$-1.42M |
|
$-1.42M |
|
$-1.42M |
|
$-1.42M |
|
$-1.41M |
|
$-1.41M |
|
42.02M |
|
42.02M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$7.23M |
|
-- |
|
$0.04M |
|
$7.27M |
|
$0.43M |
|
-- |
|
-- |
|
$0.43M |
|
$6.84M |
|
|
Tangible Shareholders Equity |
$6.84M |
$6.84M |
|
42.02M |
|
| Cash Flow Statement Financials | |
$-3.71M |
|
-- |
|
$-0.14M |
|
$6.35M |
|
$2.50M |
|
$-3.84M |
|
$0.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.97 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.71M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-20.80% |
|
-20.80% |
|
-19.58% |
|
-20.80% |
|
$0.16 |
|
$-0.09 |
|
$-0.09 |
|